ANDATOPICALLOTION, AUGMENTED
Approved
May 2007
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action of betamethasone dipropionate lotion (augmented), 0.05% in corticosteroid responsive dermatoses is unknown.
Clinical Trials (1)
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.
Started Feb 2007
200 enrolled
Psoriasis